Shots: Study involves assessing of inhaled TLR9 agonist with anti-PD-1 in mouse preclinical model, leading a long term survival in two different mouse lung tumour models Administration of SD-101 in lungs of mice with metastatic tumours results in ~90% reduction in tumour burden in lung and liver both enhancing survival time and survival rate of […]Read More
Tags : lungcancer
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US